Science · 2001 · 277 citations · 8 references
MedicineCancer BiologyOncologyCancer PharmacologyMolecular OncologyTumor ProgressionApoptosis ResistanceCancer ProgressionDrug Resistance NetworksTherapeutic ResistanceAnticancer Drug ResistanceClinical Resistance EvolutionResistance To Targeted TherapyReversal Of Drug ResistanceTherapeutic Resistance Mechanisms
STI-571, a new Abl tyrosine kinase inhibitor recently approved by the Food and Drug Administration, is highly effective in treating the early stages of chronic myeloid leukemia (CML), but remissions induced in advanced phases tend to be relatively short-lived, an observation that suggests the
8
Brian Druker, Charles L. Sawyers, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2001 · 2.7K citations · Full text
Medicine, Hematology, Oncology +17
François Xavier Mahon, Michael W. Deininger, Beate Schultheis et al. · Blood · 2000 · 760 citations